{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:58:50Z","timestamp":1790881130769,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Numerous observational studies have suggested a potential shared genetic background between inflammatory bowel disease (IBD) and IgA vasculitis (IgAV). However, the causal relationship between these 2 conditions remains poorly understood. We performed large-scale two-sample and multivariable Mendelian randomization (MR) analyses (MVMR) to examine whether there is a causal relationship between IBD and IgAV. We employed 4 distinct approaches, including MR-Egger, weighted median, random-effects inverse-variance weighted (IVW), and weighted mode, to conduct the MR analysis. The univariable MR analysis demonstrated that IBD and Crohn disease (CD) were associated with an increased risk of IgAV in the International Inflammatory Bowel Disease Genetics Consortium, with an odds ratio (OR) of 1.17 (95% confidence interval [CI]: 1.06\u20131.28,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>IVW<\/jats:sub>\n                      \u2005=\u2005.001) for IBD and an OR of 1.12 (95% CI: 1.01\u20131.24,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>IVW<\/jats:sub>\n                      \u2005=\u2005.016) for CD. Ulcerative colitis was associated with an increased risk of IgAV, which was considered suggestive after Bonferroni correction, with an OR of 1.12 (95% CI: 1.01\u20131.24,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>IVW<\/jats:sub>\n                      \u2005=\u2005.028). Consistent results were observed after adjusting for potential confounders (drug allergy and upper respiratory tract infection) in MVMR. IBD, ulcerative colitis, and CD were associated with an increased risk of IgAV, with an OR of 1.20 (95% CI: 1.08\u20131.34,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>IVW<\/jats:sub>\n                      \u2005=\u2005.001), 1.20 (95% CI: 1.07\u20131.35,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>IVW<\/jats:sub>\n                      \u2005=\u2005.002), and 1.13 (95% CI: 1.03\u20131.25,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>IVW<\/jats:sub>\n                      \u2005=\u2005.0012). Our study identifies a causal relationship between IBD and IgAV, particularly between CD and IgAV, suggesting that IBD is a potential precursor to IgAV rather than the converse. Further studies on the common mechanisms of these 2 diseases are needed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049953","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:01:32Z","timestamp":1784919692000},"page":"e49953","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Investigating causal associations between inflammatory bowel disease and IgA vasculitis: Univariable and multivariable Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"given":"Bingqing","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Nursing, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyue","family":"Luo","sequence":"additional","affiliation":[{"name":"College of Nursing, Hunan University of Chinese Medicine, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/gutjnl-2022-329304","article-title":"Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding.","volume":"72","author":"Laube","year":"2023","journal-title":"Gut"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1038\/s41467-021-25768-0","article-title":"Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases.","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/metabo13060730","article-title":"Causal effects of blood lipid traits on inflammatory bowel diseases: a Mendelian randomization study.","volume":"13","author":"Yao","year":"2023","journal-title":"Metabolites"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"771619","DOI":"10.3389\/fimmu.2021.771619","article-title":"Pathogenesis of IgA vasculitis: an up-to-date review.","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1038\/s41598-017-03915-2","article-title":"A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis.","volume":"7","author":"L\u00f3pez-Mej\u00edas","year":"2017","journal-title":"Sci Rep"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","article-title":"IgA vasculitis (Henoch-Sh\u00f6nlein purpura) in adults: diagnostic and therapeutic aspects.","volume":"14","author":"Audemard-Verger","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11926-018-0735-3","article-title":"IgA vasculitis: genetics and clinical and therapeutic management.","volume":"20","author":"Gonz\u00e1lez-Gay","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/joneph\/19.3.387","article-title":"Henoch-Sch\u00f6nlein purpura and Crohn\u2019s disease in a family.","volume":"19","author":"Cassater","year":"2006","journal-title":"J Nephrol"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/pde.14818","article-title":"Henoch Schonlein purpura in pediatric patients with inflammatory bowel disease: a case series.","volume":"38","author":"Sheth","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/rheumatology\/keab662","article-title":"IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-\u03b1 blockers.","volume":"61","author":"Rasmussen","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","article-title":"European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.","volume":"58","author":"Ozen","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.","volume":"49","author":"de Lange","year":"2017","journal-title":"Nat Genet"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/bioinformatics\/btu779","article-title":"SNiPA: an interactive, genetic variant-centered annotation browser.","volume":"31","author":"Arnold","year":"2015","journal-title":"Bioinformatics"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique.","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/gepi.22442","article-title":"The influence of unmeasured confounding on the MR Steiger approach.","volume":"46","author":"Lutz","year":"2022","journal-title":"Genet Epidemiol"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41467-019-14156-4","article-title":"A robust and efficient method for Mendelian randomization with hundreds of genetic variants.","volume":"11","author":"Burgess","year":"2020","journal-title":"Nat Commun"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/03009742.2020.1732460","article-title":"Immunoglobulin A vasculitis associated with inflammatory bowel disease: a retrospective cohort study.","volume":"50","author":"Villatoro-Villar","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s12328-021-01456-w","article-title":"Henoch-Sch\u00f6nlein purpura and Crohn\u2019s disease: expanding the range of association in pediatric patients.","volume":"14","author":"Hong","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.autrev.2017.11.024","article-title":"Genetics of immunoglobulin-A vasculitis (Henoch-Sch\u00f6nlein purpura): an updated review.","volume":"17","author":"L\u00f3pez-Mej\u00edas","year":"2018","journal-title":"Autoimmun Rev"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1399-0039.2009.01241.x","article-title":"HLA-B is the best candidate of susceptibility genes in HLA for Japanese ulcerative colitis.","volume":"73","author":"Aizawa","year":"2009","journal-title":"Tissue Antigens"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/j.gastro.2011.05.048","article-title":"HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn\u2019s disease.","volume":"141","author":"Okada","year":"2011","journal-title":"Gastroenterology"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2011.02.046","article-title":"Recent insights into the genetics of inflammatory bowel disease.","volume":"140","author":"Cho","year":"2011","journal-title":"Gastroenterology"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"853724","DOI":"10.3389\/fped.2022.853724","article-title":"New insights and challenges associated with IgA vasculitis and IgA vasculitis with nephritis \u2013 is it time to change the paradigm of the most common systemic vasculitis in childhood?","volume":"10","author":"Jelusic","year":"2022","journal-title":"Front Pediatr"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ckj\/sfz004","article-title":"Inflammatory bowel disease in patients undergoing renal biopsies.","volume":"12","author":"Pohjonen","year":"2019","journal-title":"Clin Kidney J"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-immunol-030409-101314","article-title":"Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis.","volume":"28","author":"Fagarasan","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.coi.2004.03.005","article-title":"Regulation of IgA synthesis at mucosal surfaces.","volume":"16","author":"Fagarasan","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"aaf4822","DOI":"10.1126\/science.aaf4822","article-title":"IgA production requires B cell interaction with subepithelial dendritic cells in Peyer\u2019s patches.","volume":"352","author":"Reboldi","year":"2016","journal-title":"Science"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ibd\/izad024","article-title":"The underappreciated role of secretory IgA in IBD.","volume":"29","author":"Bamias","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1172\/JCI20096","article-title":"Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy.","volume":"113","author":"Wang","year":"2004","journal-title":"J Clin Invest"},{"key":"R36-20261001","first-page":"928461","article-title":"Role of Th17 cells in the pathogenesis of human IBD.","volume":"2014","author":"G\u00e1lvez","year":"2014","journal-title":"ISRN Inflamm"},{"key":"R37-20261001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.intimp.2013.03.027","article-title":"The imbalance of Th17\/Treg in Chinese children with Henoch-Schonlein purpura.","volume":"16","author":"Chen","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"R38-20261001","doi-asserted-by":"crossref","first-page":"e072148","DOI":"10.1136\/bmj-2022-072148","article-title":"A framework for assessing selection and misclassification bias in Mendelian randomisation studies: an illustrative example between body mass index and COVID-19.","volume":"381","author":"Clayton","year":"2023","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:01:07Z","timestamp":1790877667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":38,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049953","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"2026-05-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}